Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C4 | P17516 | 1/20 | 0.66 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.66 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.66 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.30 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26626337 | 0.88 | AKR1C4 (0.71) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL19604584 | 0.88 | AKR1C4 (0.71) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL14373673 | 0.88 | AKR1C4 (0.71) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL19604624 | 0.88 | AKR1C4 (0.71) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL11846544 | 0.83 | AKR1C4 (0.70) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL11846528 | 0.83 | AKR1C4 (0.70) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL13632484 | 0.83 | AKR1C4 (0.66) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL26658203 | 0.83 | AKR1C4 (0.66) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL13523023 | 0.83 | AKR1C4 (0.70) | AKR1C4AKR1C3AKR1C2HTTPTGER2 | |
| SCHEMBL21400732 | 0.81 | AKR1C4 (0.76) | AKR1C4AKR1C3AKR1C2HTTPTGER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019182527-A1 | METHYL JASMONATE DERIVATIVES AS POSSIBLE DRUG CANDIDATES FOR USE IN TREATMENT OF CANCER | T.C. ISTANBUL MEDIPOL UNIVERSITESI (TR) | 2019-09-26 | — | — | WO | disclosed |